Iqvia Holdings Inc.
A health-intelligence giant that helps drugmakers run clinical trials, sell their medicines, and make sense of huge piles of healthcare data—drawing on a trove covering roughly nine in ten of the world's pharmaceuticals. It was born in 2016 when Quintiles, the contract-research firm founded by a statistics professor in 1982, merged with IMS Health, a market-data company from 1954. Its name blends letters from both: the "I" from IMS and "Q" from Quintiles, plus "VIA" for the road ahead.
Granted 1.6K
Granted 1.6K
Granted 1.6K
Granted 1.6K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Danhakl John GDirector · 1 transaction | +5.2% | 31.9K | 1.6K | — | — |
| Leonard John MDirector · 1 transaction | +10.2% | 16.9K | 1.6K | — | — |
| Goggins Colleen ADirector · 1 transaction | +12.2% | 14.5K | 1.6K | — | — |
| Burt CarolDirector · 1 transaction | +26.4% | 7.5K | 1.6K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.